UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevention and treatment of Clostridium difficile associated diarrhea by reconstitution of the microbiota

Human vaccines & immunotherapeutics, 2019-06, Vol.15 (6), p.1453-1456

2019

Volltextzugriff (PDF)

Medical perspectives on Israeli children after their release from captivity – A retrospective study

Acta Paediatrica, 2024-10, Vol.113 (10), p.2259-2265

2024

Volltextzugriff (PDF)

Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years

JAMA : the journal of the American Medical Association, 2021-12, Vol.326 (21), p.2203

2021

Volltextzugriff (PDF)

Does accepted definition of Clostridioides difficile infection (CDI) severity predict poor outcomes in older adults?

Aging clinical and experimental research, 2022-03, Vol.34 (3), p.583-589

2022

Volltextzugriff (PDF)

Risk-factors for re-admission and outcome of patients hospitalized with confirmed COVID-19

Scientific reports, 2021-08, Vol.11 (1), p.17416-17416, Article 17416

2021

Volltextzugriff (PDF)

Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial

Clinical infectious diseases, 2019-09, Vol.69 (7), p.1091-1098

2019

Volltextzugriff (PDF)

Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection-- 7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials

Journal of antimicrobial chemotherapy, 2013-10, Vol.68 (10), p.2183-2191

2013

Volltextzugriff (PDF)

Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer

JAMA oncology, 2021-08, Vol.7 (8), p.1133

2021

Volltextzugriff (PDF)

Risk factors for hospital readmission following complicated urinary tract infection

Scientific reports, 2021-03, Vol.11 (1), p.6926-6926, Article 6926

2021

Volltextzugriff (PDF)

Influenza vaccines in immunosuppressed adults with cancer

Cochrane database of systematic reviews, 2018-02, Vol.2 (2), p.CD008983-CD008983

2018

Volltextzugriff (PDF)

Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment

JAMA oncology, 2021-11, Vol.7 (11), p.1716

2021

Volltextzugriff (PDF)

Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials

Journal of antimicrobial chemotherapy, 2015-04, Vol.70 (4), p.979-996

2015

Volltextzugriff (PDF)

Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections

Antimicrobial resistance & infection control, 2018-09, Vol.7 (1), p.111-111, Article 111

2018

Volltextzugriff (PDF)

Influenza vaccines in immunosuppressed adults with cancer

Cochrane database of systematic reviews, 2013-10, Vol.2013 (10), p.CD008983-CD008983

2013

Volltextzugriff (PDF)

Risk factors for short‐ and long‐term mortality in very old patients with Clostridium difficile infection: A retrospective study

Geriatrics & gerontology international, 2017-10, Vol.17 (10), p.1378-1383

2017

Volltextzugriff (PDF)

Predicting In-Hospital Antibiotic Use in the Medical Department: Derivation and Validation Study

Antibiotics (Basel), 2022-06, Vol.11 (6), p.813

2022

Volltextzugriff (PDF)

Improved immunogenicity following the third dose of BNT162b2 mRNA vaccine in heart transplant recipients

European journal of cardio-thoracic surgery, 2022-09, Vol.62 (4)

2022

Volltextzugriff (PDF)

A comparison of predictors for mortality and bacteraemia in patients suspected of infection

BMC infectious diseases, 2021-08, Vol.21 (1), p.864-10, Article 864

2021

Volltextzugriff (PDF)

Immunogenicity of the BNT162b2 mRNA vaccine in heart transplant recipients – a prospective cohort study

European journal of heart failure, 2021-09, Vol.23 (9), p.1555-1559

2021

Volltextzugriff (PDF)

Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults

JAMA network open, 2022-07, Vol.5 (7), p.e2223090-e2223090

2022

Volltextzugriff (PDF)

Antiviral therapy in cytomegalovirus-positive ulcerative colitis:A systematic review and meta-analysis

World journal of gastroenterology : WJG, 2014-03, Vol.20 (10), p.2695-2703

2014

Volltextzugriff (PDF)

Six‐months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device‐supported patients

ESC Heart Failure, 2022-04, Vol.9 (2), p.905-911

2022

Volltextzugriff (PDF)

Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study

PloS one, 2021-11, Vol.16 (11), p.e0259707-e0259707

2021

Volltextzugriff (PDF)

A Biphasic COVID-19 Clinical Course in Anti-CD20 Treated Patients: Case Series and Review of the Literature

European journal of case reports in internal medicine, 2022-08, Vol.9 (8), p.003502-003502

2022

Volltextzugriff (PDF)

A Transient Inflammatory Reaction with a B-Cell Lymphoid Infiltrate and Dysplastic Bone Marrow Changes Associated with the BNT162b2 COVID-19 Vaccine

European journal of case reports in internal medicine, 2022-06, Vol.9 (6), p.003381-003381

2022

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(116)
Berichte
(1)

Sprache

Englisch
(116)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(87)
Life Sciences & Biomedicine
(84)
Humans
(61)
Infectious Diseases
(40)
Female
(36)
Male
(34)
Aged
(25)
Middle Aged
(24)
Adult
(23)
Microbiology
(23)
Risk Factors
(21)
General & Internal Medicine
(20)
Medicine, General & Internal
(20)
Retrospective Studies
(20)
Antibiotics
(16)
Patients
(16)
Anti-Bacterial Agents - Therapeutic Use
(15)
Aged, 80 And Over
(13)
Treatment Outcome
(13)
Hospitalization
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prevention and treatment of Clostridium difficile associated diarrhea by reconstitution of the microbiota

Medical perspectives on Israeli children after their release from captivity – A retrospective study

Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years

Does accepted definition of Clostridioides difficile infection (CDI) severity predict poor outcomes in older adults?

Risk-factors for re-admission and outcome of patients hospitalized with confirmed COVID-19

Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial

Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection-- 7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials

Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer

Risk factors for hospital readmission following complicated urinary tract infection

Influenza vaccines in immunosuppressed adults with cancer

Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment

Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials

Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections

Influenza vaccines in immunosuppressed adults with cancer

Risk factors for short‐ and long‐term mortality in very old patients with Clostridium difficile infection: A retrospective study

Predicting In-Hospital Antibiotic Use in the Medical Department: Derivation and Validation Study

Improved immunogenicity following the third dose of BNT162b2 mRNA vaccine in heart transplant recipients

A comparison of predictors for mortality and bacteraemia in patients suspected of infection

Immunogenicity of the BNT162b2 mRNA vaccine in heart transplant recipients – a prospective cohort study

Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults

Antiviral therapy in cytomegalovirus-positive ulcerative colitis:A systematic review and meta-analysis

Six‐months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device‐supported patients

Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study

A Biphasic COVID-19 Clinical Course in Anti-CD20 Treated Patients: Case Series and Review of the Literature

A Transient Inflammatory Reaction with a B-Cell Lymphoid Infiltrate and Dysplastic Bone Marrow Changes Associated with the BNT162b2 COVID-19 Vaccine

Suchergebnisse filtern